Latest news on Alzheimer's

The new unit will strengthen innovation and knowledge and technology transfer to bring scientific advances closer to society

Available to researchers worldwide upon request, the dataset includes clinical, cognitive, genetic, neuroimaging and cerebrospinal fluid biomarker data from participants in the ALFA+ study.

The study identifies protein signatures specific to Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and integrates them into a single quantitative biomarker panel.

The results offer a new evolutionary perspective on human health and help explain why many genetic variants associated with common diseases have been maintained throughout evolution

The BBRC reaches a historic milestone that reflects years of collective effort, cutting-edge technology and an open, collaborative science model.

The centre’s research staff will present 7 talks and 25 scientific posters at the world’s largest Alzheimer’s conference.

The addition brings the total number of groups at the research center to nine and strengthens its capabilities in molecular epidemiology, biostatistics, and data science as applied to Alzheimer’s disease and brain health

The study provides preliminary evidence that the number of births may only influence cognitive decline in women who already have high levels of β-amyloid protein in their brain

The study shows that certain blood biomarkers can help rule out the presence of Alzheimer’s disease pathology in people with subjective memory complaints, although lumbar puncture remains necessary to confirm the diagnosis.